Back to search
Schizophrenia, Catatonic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophrenia, Catatonic trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophrenia, Catatonic trials you may qualify forIn its 2012's release guideline on therapy for schizophrenia, the EMA joined the FDA to acknowledge primary and persistent negative symptoms (PNS) as an unmet n…
Evaluation effectiveness and safety of TMS in subjects with catatonia
The aim of this study is to identify specifics of pre-ECT assessments and ECT application in European psychiatric services. We will engage European centres that…
The different subtypes of Schizophrenia might have a disordered connectivity as their final common pathways. The investigators will use multimodal structural M…
This study will evaluate whether talnetant (200mg, 400mg, 600mg) twice a day is effective compared to placebo and risperidone 1-3mg twice a day in treating the…
The purpose of this study is to examine treatment practices of adult schizophrenia patients by their own doctors, and to assess patient outcomes when treated wi…
Randomized, controlled, double-blind, two-armed clinical investigation to show the efficacy and safety of transcutaneous vagus nerve stimulation (t-VNS), applie…
The purpose of this study is to evaluate the efficacy, tolerability and safety of patients on long-acting Risperidone microshpheres injection. The major advanta…